The billionaire Democratic governor disclosed a diabetes diagnosis and two years of medication use in a CBS interview, a personal reveal that lands as he navigates questions about a possible 2028 presidential bid.
JB Pritzker, 61, told CBS on Monday that routine blood work two years ago showed he had diabetes. His doctor prescribed a GLP-1 medication, the same class of drugs that includes popular weight-loss treatments, and told him he would need to stay on it permanently. Since then, Pritzker said, he has dropped 80 pounds.
The Illinois governor paired the disclosure with a policy announcement: his state now covers GLP-1 medications on its insurance plan for 55,000 civil servants, a move he said would save money by preventing other diseases down the road.
Pritzker did not name the specific drug he takes. He did not say what type of diabetes he was diagnosed with or reveal his starting weight. But the interview gave the public its first detailed look at a transformation that has been visible for months, and that carries obvious political implications for a governor who has not ruled out a White House run.
Pritzker framed the weight loss as deeply personal. His father, he said, died of a heart attack at just 39 years old, on a tennis court, with Pritzker's mother beside him.
"He was actually quite an active person, even though he was overweight, and so he was on a tennis court and had a heart attack, and my mother was there, and he died in her arms."
That family history, Pritzker said, has driven him his entire life to try to lose weight. The GLP-1 medication finally made it possible.
He described the drug's effect as striking. By the third day, he said, his appetite had changed.
"All of a sudden, on the third day, I was like, you know, actually, I don't need to eat that thing."
He lost two pounds in his first week. But Pritzker was careful to temper expectations, adding that the change did not happen overnight: "It was the strangest feeling. Now, I'm not suggesting everything changed in a week. It didn't happen that way."
Beyond the medication, Pritzker said he now takes a four-mile morning walk along Lake Michigan. He described himself as feeling "a whole lot different and a whole lot better."
The CBS interview inevitably turned to presidential politics. Pritzker gave the kind of answer that keeps options open without committing to anything.
"I have not made any decisions about what I might do in the future. I can tell you I want to be the governor of the state of Illinois for a while longer, and I'm running for reelection."
He also tied the weight-loss question directly to his ambition, saying the GLP-1 breakthrough "has meant a lot to me" after a lifetime of trying and failing to shed weight.
Early 2028 Democratic primary polling suggests Pritzker has a long climb. A Harvard CAPS/Harris survey published earlier this month put him at just 4 percent, far behind Kamala Harris at 42 percent, Gavin Newsom at 18 percent, and Pete Buttigieg and Alexandria Ocasio-Cortez each at 9 percent. Josh Shapiro and Jon Ossoff both polled at 7 percent.
A Bowling Green State University/YouGov poll from September told a similar story. Harris led at 17 percent, followed by Buttigieg at 16 percent, Newsom at 14 percent, and Ocasio-Cortez at 14 percent. Pritzker did not appear among the leading tier.
Pritzker used the personal disclosure to bolster a policy decision. Illinois now covers GLP-1 drugs through its state employee insurance plan, extending the benefit to 55,000 civil servants. Pritzker argued the coverage will pay for itself by preventing costlier diseases.
That claim deserves scrutiny. GLP-1 medications can run over $1,000 a month without insurance, and the long-term fiscal picture for state plans that cover them remains unclear. Pritzker offered no specific dollar estimate for projected savings, and the state has not disclosed whether the coverage applies only to diabetes patients, only to weight loss, or both.
For Illinois taxpayers already shouldering one of the heaviest state-debt burdens in the country, the promise that a new drug benefit "will save money" is one they have heard before, on pensions, on Medicaid expansion, on program after program. The savings rarely materialize on schedule, and the costs always do.
During the 2024 presidential campaign, Donald Trump took a shot at Pritzker's weight at a rally, saying: "Pritzker, I don't know, he's too busy eating. He wants to eat all the time."
That jab landed when Pritzker was already quietly on the medication, if his two-year timeline is accurate. He chose not to respond publicly at the time. Now, with 80 fewer pounds and a governor's reelection ahead, he has chosen to make the disclosure on national television, on his terms, in a sympathetic interview setting.
Nothing about the timing is accidental. A governor sitting at 4 percent in early presidential polls, carrying a personal fortune and a newly slim frame, does not go on CBS to talk about his health journey without thinking about what comes next. Pritzker says he has made no decisions. His schedule suggests otherwise. He spoke at the National Action Network Convention in New York in April and appeared at a Chicago rally in June 2025, the kind of calendar that belongs to someone testing the water, not someone content to govern from Springfield.
Voters deserve the health information, and Pritzker is free to take whatever medication his doctor prescribes. But when a billionaire governor reveals a dramatic physical transformation on a timeline that aligns perfectly with a presidential cycle, the public is right to notice the packaging as much as the product.
